Ecovyst Q4 sales growth beat analyst expectations

Reuters
Feb 26
Ecovyst Q4 sales growth beat analyst expectations

Overview

  • Sulfuric acid provider's Q4 sales rose 33.9% yr/yr, beating analyst expectations

  • Adjusted net income for Q4 beat analyst expectations

  • Company completed sale of Advanced Materials & Catalysts segment for $556 mln

Outlook

  • Ecovyst expects 2026 sales between $860 mln and $940 mln

  • Company anticipates 2026 adjusted EBITDA of $175 mln to $195 mln

  • Ecovyst projects 2026 adjusted net income of $55 mln to $75 mln

Result Drivers

  • VIRGIN SULFURIC ACID - Higher sales volume, including contribution from Waggaman acquisition, drove sales increase

  • REGENERATED SULFURIC ACID - Favorable pricing offset by lower sales volume due to customer downtime

  • SULFUR COSTS - Pass-through effect of higher sulfur costs added $28 million to sales

Company press release: ID:nPn46RSCga

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Sales

Beat

$199.40 mln

$184.90 mln (5 Analysts)

Q4 Adjusted Net Income

Beat

$32.40 mln

$17.51 mln (5 Analysts)

Q4 Net Income

$5.80 mln

Q4 Adjusted EBITDA

Beat

$51.30 mln

$48.62 mln (6 Analysts)

Q4 Gross Profit

$46.80 mln

Q4 Operating Income

$21.80 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the diversified chemicals peer group is "buy"

  • Wall Street's median 12-month price target for Ecovyst Inc is $12.00, about 6% above its February 25 closing price of $11.32

  • The stock recently traded at 19 times the next 12-month earnings vs. a P/E of 13 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10